250 related articles for article (PubMed ID: 35794285)
21. Association of Pharmacist-led Deprescribing Intervention with the Functional Recovery in Convalescent Setting.
Kose E; Endo H; Hori H; Hosono S; Kawamura C; Kodama Y; Yamazaki T; Yasuno N
Pharmazie; 2022 May; 77(5):165-170. PubMed ID: 35655381
[TBL] [Abstract][Full Text] [Related]
22. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
Sanyal C; Turner JP; Martin P; Tannenbaum C
J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
[TBL] [Abstract][Full Text] [Related]
23. Process evaluation of a pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among adult people with type 2 diabetes.
Baas G; Crutzen S; Smits S; Denig P; Taxis K; Heringa M
Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):83-96. PubMed ID: 37563775
[TBL] [Abstract][Full Text] [Related]
24. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
[TBL] [Abstract][Full Text] [Related]
25. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
[TBL] [Abstract][Full Text] [Related]
27. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
Kassis A; Moles R; Carter S
Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
[TBL] [Abstract][Full Text] [Related]
28. Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.
Isenor JE; Bai I; Cormier R; Helwig M; Reeve E; Whelan AM; Burgess S; Martin-Misener R; Kennie-Kaulbach N
Res Social Adm Pharm; 2021 Jul; 17(7):1229-1241. PubMed ID: 32978088
[TBL] [Abstract][Full Text] [Related]
29. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
Leszcynski L; Bente J
Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
[No Abstract] [Full Text] [Related]
30. Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs.
Bai I; Isenor JE; Reeve E; Whelan AM; Martin-Misener R; Burgess S; Kennie-Kaulbach N
Res Social Adm Pharm; 2022 Aug; 18(8):3350-3357. PubMed ID: 34895842
[TBL] [Abstract][Full Text] [Related]
31. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
[TBL] [Abstract][Full Text] [Related]
32. A virtual breakthrough series collaborative to support deprescribing interventions across Veterans Affairs healthcare settings.
Phillips KK; Mecca MC; Baim-Lance AM; Schiller GS; Pruskowski JA; Ellis EC; Aponte-Rosario DS; Federovich-Hogan AL; Kossifologos AC; Martinez ED; Boockvar KS
J Am Geriatr Soc; 2023 Sep; 71(9):2935-2945. PubMed ID: 37337658
[TBL] [Abstract][Full Text] [Related]
33. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
Mena S; Moullin JC; Schneider M; Niquille A
BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
[TBL] [Abstract][Full Text] [Related]
34. Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists.
Turner JP; Sanyal C; Martin P; Tannenbaum C
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1061-1067. PubMed ID: 32761069
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit.
Potter EL; Lew TE; Sooriyakumaran M; Edwards AM; Tong E; Aung AK
Australas J Ageing; 2019 Sep; 38(3):206-210. PubMed ID: 30868694
[TBL] [Abstract][Full Text] [Related]
36. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
[TBL] [Abstract][Full Text] [Related]
37. Pharmacist-Led Deprescribing of Aspirin in Older People in an Outpatient Setting.
Ramos VH; Hayes L; Simmons K; Trudeau B; Boka A
Sr Care Pharm; 2024 Jun; 39(6):212-217. PubMed ID: 38803027
[No Abstract] [Full Text] [Related]
38. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
39. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
Gendre P; Mayol S; Mocquard J; Huon JF
Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
[TBL] [Abstract][Full Text] [Related]
40. Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study.
Bužančić I; Ortner Hadžiabdić M
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
